|
1
|
Wagner JC, Sleggs CA and Marchand P:
Diffuse pleural mesothelioma and asbestos exposure in the North
Western Cape Province. Br J Ind Med. 17:260–271. 1960.PubMed/NCBI
|
|
2
|
Boffetta P: Health effects of asbestos
exposure in humans: a quantitative assessment. Med Lav. 89:471–480.
1998.PubMed/NCBI
|
|
3
|
International Agency for Research on
Cancer, . Asbestos (Chrysolite, Amosite, Crocidolite, Tremolite,
Actinolite, and Anthophyllite)IARC Monographs. Arsenic, Metals,
Fibres and Dusts. International Agency for Research on Cancer;
Lyon: pp. 147–167. 2009
|
|
4
|
Tan C and Treasure T: Mesothelioma: time
to take stock. J R Soc Med. 98:455–458. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Robinson BW and Lake RA: Advances in
malignant mesothelioma. N Engl J Med. 353:1591–1603. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
McDonald JC and McDonald AD: The
epidemiology of mesothelioma in historical context. Eur Respir J.
9:1932–1942. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Crisstaudo A, Foddis R and Guglielmi G:
Methodology and results of an experience of medical surveillance of
people previously exposed to asbestos in Tuscany. G Ital Med Lav
Ergon. 32(Suppl 4): 385–388. 2010.(In Italian). PubMed/NCBI
|
|
8
|
Marcus PM, Bergstralh EJ, Fagerstrom RM,
Williams DE, Fontana R, Taylor WF and Prorok PC: Lung cancer
mortality in the Mayo Lung Project: impact of extended follow-up. J
Natl Cancer Inst. 92:1308–1316. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Loreto C, Rapisarda V, Carnazza ML,
Musumeci G, Valentino M, Fenga C and Martinez G: Fluoro-edenite
fibres induce lung cell apoptosis: an in vivo study. Histol
Histopathol. 23:319–326. 2008.PubMed/NCBI
|
|
10
|
Pass HI, Levin SM, Harbut MR, Melamed J,
Chiriboga L, Donington J, Huflejt M, Carbone M, Chia D, Goodglick
L, et al: Fibulin-3 as a blood and effusion biomarker for pleural
mesothelioma. N Engl J Med. 367:1417–1427. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rapisarda V, Ledda C, Migliore M, Salemi
R, Musumeci A, Bracci M, Marconi A, Loreto C and Libra M: FBLN-3 as
a biomarker of pleural plaques in workers occupationally exposed to
carcinogenic fibers: a pilot study. Future Oncol. 11(Suppl 24):
35–37. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bruni BM, Pacella A, MazziottiTagliani S,
Gianfagna A and Paoletti L: Nature and extent of the exposure to
fibrous amphiboles in Biancavilla. Sci Total Environ. 370:9–16.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Putzu MG, Bruno C, Zona A, Massiccio M,
Pasetto R, Piolatto PG and Comba P: Fluoro-edenitic fibres in the
sputum of subjects from Biancavilla (Sicily): a pilot study.
Environ Health. 5:202006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ledda C, Rapisarda V, Bracci M, Proietti
L, Zuccarello M, Fallico R, Fiore M and Ferrante M: Professional
exposure to basaltic rock dust: assessment by the Vibrio fischeri
ecotoxicological test. J Occup Med Toxicol. 8:232013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wright CM, Francis SM Savarimuthu, Tan ME,
Martins MU, Winterford C, Davidson MR, Duhig EE, Clarke BE, Hayward
NK, Yang IA, et al: MS4A1 dysregulation in asbestos-related lung
squamous cell carcinoma is due to CD20 stromal lymphocyte
expression. PLoS One. 7:e349432012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Polesel J, Franceschi S, Talamini R, Negri
E, Barzan L, Montella M, Libra M, Vaccher E, Franchin G, La Vecchia
C and Serraino D: Tobacco smoking, alcohol drinking, and the risk
of different histological types of nasopharyngeal cancer in a
low-risk population. Oral Oncol. 47:541–545. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
De Nardo P: More attention to veterinarian
epidemiologists. Epidemiol Prev. 28:1942004.(In Italian).
PubMed/NCBI
|
|
18
|
Paoletti L, Batisti D, Bruno C, Di Paola
M, Gianfagna A, Mastrantonio M, Nesti M and Comba P: Unusually high
incidence of malignant pleural mesothelioma in a town of eastern
Sicily: an epidemiological and environmental study. Arch Environ
Health. 55:392–398. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
International Agency for Research on
Cancer, . IARC Monographs on the evaluation of carcinogenic risks
to humans. Supplement 7:1-42. IARC Press; Lyon: 1987
|
|
20
|
Committee on Asbestos: Selected Health
Effects; Board on Population Health and Public Health Practices;
Institute of Medicine, . Asbestos: Selected Cancers. The National
Academies Press; Washington, DC: 2006
|
|
21
|
Goldberg M and Luce D: The health impact
of nonoccupational exposure to asbestos: what do we know? Eur J
Cancer Prev. 18:489–503. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cardile V, Lombardo L, Belluso E, Panico
A, Renis M, Gianfagna A and Balazy M: Fluoro-edenite fibers induce
expression of Hsp70 and inflammatory response. Int J Environ Res
Public Health. 4:195–202. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Musumeci G, Cardile V, Fenga C, Caggia S
and Loreto C: Mineral fibre toxicity: Expression of retinoblastoma
(Rb) and phospho-retinoblastoma (pRb) protein in alveolar
epithelial and mesothelial cell lines exposed to fluoro-edenite
fibres. Cell Biol Toxicol. 27:217–225. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chu IM, Hengst L and Slingerland JM: The
Cdk inhibitor p27 in human cancer: prognostic potential and
relevance to anticancer therapy. Nat Rev Cancer. 8:253–267. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Baldassarre G, Belletti B, Nicoloso MS,
Schiappacassi M, Vecchione A, Spessotto P, Morrione A, Canzonieri V
and Colombatti A: p27(Kip1)-stathmin interaction influences sarcoma
cell migration and invasion. Cancer Cell. 7:51–63. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sonego M, Schiappacassi M, Lovisa S,
Dall'Acqua A, Bagnoli M, Lovat F, Libra M, D'Andrea S, Canzonieri
V, Militello L, et al: Stathmin regulates mutant p53 stability and
transcriptional activity in ovarian cancer. EMBO Mol Med.
5:707–722. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
McCubrey JA, Abrams SL, Ligresti G,
Misaghian N, Wong EW, Steelman LS, Bäsecke J, Troppmair J, Libra M,
Nicoletti F, et al: Involvement of p53 and Raf/MEK/ERK pathways in
hematopoietic drug resistance. Leukemia. 22:2080–2090. 2008.
View Article : Google Scholar : PubMed/NCBI
|
